New phase 2 findings published in NEJM
Doctors drill hole in mother's skull, moments before her C-section
Distinguished clinician, researcher and author brings more than 27 years of expertise in Alzheimer’s disease to lead one of the largest memory disorders group in the country
Assessment reveals desperately slow period in drug development, with only eight new agents entering Phase I since 2016
